<bill session="103" type="h" number="4" updated="2010-04-18T23:00:25-04:00">
	<state datetime="1993-03-11T14:11:00-05:00">PASS_OVER:HOUSE</state>
	<status><vote datetime="1993-03-11T14:11:00-05:00" where="h" result="pass" how="roll" roll="69"/></status>

	<introduced datetime="1993-01-05"/>
	<titles>
		<title type="popular" as="">Fetal Tissue Research bill</title>
		<title type="popular" as="">National Institutes of Health Revitalization</title>
		<title type="short" as="introduced">National Institutes of Health Revitalization Act of 1993</title>
		<title type="short" as="passed house">National Institutes of Health Revitalization Act of 1993</title>
		<title type="official" as="introduced">To amend the Public Health Service Act to revise and extend the programs of the National Institutes of Health, and for other purposes.</title>
	</titles>
	<sponsor id="400425"/>
	<cosponsors>
		<cosponsor id="400253" joined="1993-01-05"/>
		<cosponsor id="402763" joined="1993-01-05"/>
		<cosponsor id="400580" joined="1993-02-16"/>
		<cosponsor id="406873" joined="1993-01-05"/>
		<cosponsor id="400414" joined="1993-01-05"/>
		<cosponsor id="400246" joined="1993-01-05"/>
		<cosponsor id="400295" joined="1993-01-05"/>
		<cosponsor id="411040" joined="1993-01-05"/>
		<cosponsor id="410496" joined="1993-01-05"/>
		<cosponsor id="400578" joined="1993-01-05"/>
		<cosponsor id="409205" joined="1993-01-05"/>
		<cosponsor id="400409" joined="1993-01-05"/>
		<cosponsor id="300068" joined="1993-01-05"/>
		<cosponsor id="400370" joined="1993-02-03"/>
		<cosponsor id="410589" joined="1993-01-05"/>
		<cosponsor id="400524" joined="1993-01-05"/>
		<cosponsor id="406284" joined="1993-01-05"/>
		<cosponsor id="410567" joined="1993-01-26"/>
		<cosponsor id="404375" joined="1993-01-26"/>
		<cosponsor id="406729" joined="1993-01-05"/>
		<cosponsor id="409829" joined="1993-01-26"/>
		<cosponsor id="400205" joined="1993-01-05"/>
		<cosponsor id="407817" joined="1993-01-05"/>
		<cosponsor id="400436" joined="1993-01-05"/>
		<cosponsor id="409650" joined="1993-01-05"/>
		<cosponsor id="400422" joined="1993-01-05"/>
		<cosponsor id="400378" joined="1993-01-05"/>
		<cosponsor id="300091" joined="1993-01-05"/>
		<cosponsor id="400211" joined="1993-01-26"/>
		<cosponsor id="403875" joined="1993-01-05"/>
		<cosponsor id="409793" joined="1993-01-05"/>
		<cosponsor id="402152" joined="1993-02-02"/>
		<cosponsor id="400043" joined="1993-01-26"/>
		<cosponsor id="400554" joined="1993-01-05"/>
		<cosponsor id="400357" joined="1993-01-05"/>
		<cosponsor id="409627" joined="1993-01-05"/>
		<cosponsor id="400314" joined="1993-01-05"/>
		<cosponsor id="403776" joined="1993-02-17"/>
		<cosponsor id="300100" joined="1993-01-05"/>
		<cosponsor id="402762" joined="1993-01-26"/>
	</cosponsors>
	<actions>
		<action datetime="1993-01-05"><text>Referred to the House Committee on Energy and Commerce.</text></action>
		<action datetime="1993-02-03"><committee name="House Committee on Energy and Commerce"/><text>Referred to the Subcommittee on Health and the Environment.</text></action>
		<action datetime="1993-02-03"><committee name="House Committee on Energy and Commerce" subcommittee="Health and the Environment"/><text>Subcommittee Hearings Held.</text></action>
		<action datetime="1993-02-24"><committee name="House Committee on Energy and Commerce" subcommittee="Health and the Environment"/><text>Subcommittee Consideration and Mark-up Session Held.</text></action>
		<action datetime="1993-02-24"><committee name="House Committee on Energy and Commerce" subcommittee="Health and the Environment"/><text>Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 20 - 6.</text></action>
		<action datetime="1993-03-02"><committee name="House Committee on Energy and Commerce"/><text>Committee Consideration and Mark-up Session Held.</text></action>
		<calendar datetime="1993-03-02"  state="REPORTED"><committee name="House Committee on Energy and Commerce"/><text>Ordered to be Reported (Amended) by the Yeas and Nays: 34 - 10.</text></calendar>
		<action datetime="1993-03-09T12:45:00-05:00"><text>Rules Committee Resolution H. Res. 119 Reported to House. Rule provides for consideration of H.R. 4 with 1 hour of general debate. Previous question shall be considered as ordered without intervening motions except motion to recommit with or without instructions. Points of order against consideration of the bill for failure to comply with clause 2(l)(6) of rule XI are waived. It shall be in order to consider as an original bill for the purpose of amendment under the five-minute rule the amendment in the nature of a substitute recommended by the Committee on Energy and Commerce now printed in the bill. Measure will be considered read. Specified amendments are in order.</text></action>
		<action datetime="1993-03-09T13:00:00-05:00"><text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 103-28.</text></action>
		<calendar number="12" datetime="1993-03-09T13:00:00-05:00" calendar="Union" ><text>Placed on the Union Calendar, Calendar No. 12.</text></calendar>
		<action datetime="1993-03-10T15:36:00-05:00"><text>Rule H. Res. 119 passed House.</text></action>
		<action datetime="1993-03-10T15:36:00-05:00"><text>Considered under the provisions of rule H. Res. 119.</text><reference label="consideration" ref="CR H1099-1143"/></action>
		<action datetime="1993-03-10T15:36:00-05:00"><text>Rule provides for consideration of H.R. 4 with 1 hour of general debate. Previous question shall be considered as ordered without intervening motions except motion to recommit with or without instructions. Points of order against consideration of the bill for failure to comply with clause 2(l)(6) of rule XI are waived. It shall be in order to consider as an original bill for the purpose of amendent under the five-minute rule the amendment in the nature of a substitute recommended by the Committee on Energy and Commerce now printed in the bill. Measure will be considered read. Specified amendments are in order.</text></action>
		<action datetime="1993-03-10T15:36:00-05:00"><text>House resolved itself into the Committee of the Whole House on the state of the Union pursuant to H. Res. 119 and Rule XXIII.</text></action>
		<action datetime="1993-03-10T15:36:00-05:00"><text>The Speaker designated the Honorable Kweisi Mfume to act as Chairman of the Committee.</text></action>
		<action datetime="1993-03-10T15:37:00-05:00"><text>GENERAL DEBATE - The Committee of the Whole proceeded with one hour of general debate.</text></action>
		<action datetime="1993-03-10T16:43:00-05:00"><text>DEBATE - Pursuant to the provisions of H. Res. 119, the Committee of the Whole proceeded with One hour and 20 minutes of debate on the Bliley amendment and the Waxman substitute.</text></action>
		<action datetime="1993-03-10T19:00:00-05:00"><text>Committee of the Whole House on the state of the Union rises leaving H.R. 4 as unfinished business.</text></action>
		<action datetime="1993-03-11T12:59:00-05:00"><text>Considered as unfinished business.</text><reference label="consideration" ref="CR H1178-1184"/></action>
		<action datetime="1993-03-11T13:00:00-05:00"><text>The House resolved into Committee of the Whole House on the state of the Union for further consideration.</text></action>
		<action datetime="1993-03-11T13:01:00-05:00"><text>The House rose from the Committee of the Whole House on the state of the Union to report H.R. 4.</text></action>
		<action datetime="1993-03-11T13:01:00-05:00"><text>The previous question was ordered pursuant to the rule.</text></action>
		<action datetime="1993-03-11T13:55:00-05:00"><text>The House adopted the amendment in the nature of a substitute as agreed to by the Committee of the Whole House on the state of the Union.</text></action>
		<vote how="roll" type="vote" roll="69" datetime="1993-03-11T14:11:00-05:00" where="h" result="pass"  state="PASS_OVER:HOUSE"><text>On passage Passed by the Yeas and Nays: 283 - 131 (Roll no. 69).</text></vote>
		<action datetime="1993-03-11T14:11:00-05:00"><text>Motion to reconsider laid on the table Agreed to without objection.</text></action>
		<action datetime="1993-03-11T14:14:00-05:00"><text>Laid on the table. See S. 1 for further action.</text></action>
	</actions>
	<committees>
		<committee code="HSIF" name="House Energy and Commerce" activity="Referral, Markup, Reporting" />
		<committee code="" name="House Energy and Commerce" subcommittee="Health and Environment" activity="Referral, Hearings, Markup, Reporting" />
	</committees>
	<relatedbills>
		<bill relation="rule" session="103" type="hr" number="119" />
		<bill relation="superseded" session="103" type="s" number="1" />
		<bill relation="unknown" session="103" type="s" number="1" />
	</relatedbills>
	<subjects>
		<term name="Medical care"/>
		<term name="AIDS (Disease)"/>
		<term name="Abortion"/>
		<term name="Accidents"/>
		<term name="Actions and defenses"/>
		<term name="Acupuncture"/>
		<term name="Administrative procedure"/>
		<term name="Aged"/>
		<term name="Alternative medicine"/>
		<term name="Alzheimer's disease"/>
		<term name="Arthritis"/>
		<term name="Auditing"/>
		<term name="Authorization"/>
		<term name="Bioethics"/>
		<term name="Biological warfare"/>
		<term name="Bone diseases"/>
		<term name="Breast cancer"/>
		<term name="Buy American"/>
		<term name="Cancer"/>
		<term name="Cancer research"/>
		<term name="Carcinogens"/>
		<term name="Cardiovascular diseases"/>
		<term name="Cervical cancer"/>
		<term name="Child development"/>
		<term name="Child health"/>
		<term name="Chromosome mapping"/>
		<term name="Clinical trials"/>
		<term name="Communicable diseases"/>
		<term name="Communication in medicine"/>
		<term name="Communication in science"/>
		<term name="Conflict of interests"/>
		<term name="Congressional investigations"/>
		<term name="Congressional reporting requirements"/>
		<term name="Contraceptives"/>
		<term name="Cost effectiveness"/>
		<term name="Crime and criminals"/>
		<term name="Data banks"/>
		<term name="Day care"/>
		<term name="Deficiency diseases"/>
		<term name="Dentists"/>
		<term name="Department of Health and Human Services"/>
		<term name="Diabetes"/>
		<term name="Disciplining of employees"/>
		<term name="Diseases"/>
		<term name="Donation of organs, tissues, etc."/>
		<term name="Eating disorders"/>
		<term name="Education"/>
		<term name="Educational technology"/>
		<term name="Employee rights"/>
		<term name="Employee training"/>
		<term name="Environmental health"/>
		<term name="Epidemiology"/>
		<term name="Executive departments"/>
		<term name="Executive reorganization"/>
		<term name="Eye care"/>
		<term name="Eye diseases"/>
		<term name="Federal advisory bodies"/>
		<term name="Federal aid to education"/>
		<term name="Federal aid to medical education"/>
		<term name="Federal aid to medical research"/>
		<term name="Federal aid to nursing education"/>
		<term name="Federal aid to research"/>
		<term name="Federal budget process"/>
		<term name="Federal employees"/>
		<term name="Federal installations"/>
		<term name="Fetus"/>
		<term name="Fines (Penalties)"/>
		<term name="Foreign trade"/>
		<term name="Foundations"/>
		<term name="Genetic research"/>
		<term name="Geriatrics"/>
		<term name="Government paperwork"/>
		<term name="Government procurement"/>
		<term name="Government publications"/>
		<term name="Gynecology"/>
		<term name="Head injuries"/>
		<term name="Health education"/>
		<term name="Health planning"/>
		<term name="Health surveys"/>
		<term name="Homeless"/>
		<term name="Hospital personnel"/>
		<term name="Hospitals"/>
		<term name="Human behavior"/>
		<term name="Human experimentation in medicine"/>
		<term name="Human fertility"/>
		<term name="Human genetics"/>
		<term name="Human immunodeficiency viruses"/>
		<term name="Illiteracy"/>
		<term name="Infant mortality"/>
		<term name="Information services"/>
		<term name="Information storage and retrieval systems"/>
		<term name="Informed consent (Medical law)"/>
		<term name="Interstate commerce"/>
		<term name="Laboratory animals"/>
		<term name="Medical centers"/>
		<term name="Medical economics"/>
		<term name="Medical education"/>
		<term name="Medical ethics"/>
		<term name="Medical laboratories"/>
		<term name="Medical libraries"/>
		<term name="Medical personnel"/>
		<term name="Medical research"/>
		<term name="Medical residents"/>
		<term name="Medical statistics"/>
		<term name="Medical technology"/>
		<term name="Minorities"/>
		<term name="Minorities in medicine"/>
		<term name="Multiple sclerosis"/>
		<term name="Names"/>
		<term name="Nervous system diseases"/>
		<term name="New York State"/>
		<term name="Nurses"/>
		<term name="Nursing"/>
		<term name="Nursing homes"/>
		<term name="Nutrition"/>
		<term name="Nutrition and the aged"/>
		<term name="Obesity"/>
		<term name="Obstetrics"/>
		<term name="Osteoporosis"/>
		<term name="Ovarian cancer"/>
		<term name="Pain"/>
		<term name="Peer review organizations (Medicine)"/>
		<term name="Pharmaceutical research"/>
		<term name="Poor"/>
		<term name="Preventive medicine"/>
		<term name="Primates"/>
		<term name="Prostate cancer"/>
		<term name="Protection of animals"/>
		<term name="Psychology"/>
		<term name="Public health personnel"/>
		<term name="Recruiting of employees"/>
		<term name="Research and development"/>
		<term name="Research centers"/>
		<term name="Research ethics"/>
		<term name="Research grants"/>
		<term name="Right of privacy"/>
		<term name="Scholarships"/>
		<term name="Sex"/>
		<term name="Sexually transmitted diseases"/>
		<term name="Sleep disorders"/>
		<term name="Social science research"/>
		<term name="Sociology"/>
		<term name="State laws"/>
		<term name="Student loan funds"/>
		<term name="Suicide"/>
		<term name="Syndromes"/>
		<term name="Teenage pregnancy"/>
		<term name="Tissue banks"/>
		<term name="Toxicology"/>
		<term name="Transplantation of organs, tissues, etc."/>
		<term name="Trauma care"/>
		<term name="Vaccines"/>
		<term name="Violence"/>
		<term name="Washington State"/>
		<term name="Whistle blowing"/>
		<term name="Women in medicine"/>
		<term name="Women physicians"/>
		<term name="Women scientists"/>
		<term name="Women's health"/>
		<term name="Youth"/>
	</subjects>
	<amendments>
		<amendment number="h11"/>
		<amendment number="h12"/>
		<amendment number="h13"/>
		<amendment number="h14"/>
		<amendment number="h15"/>
		<amendment number="h16"/>
		<amendment number="h17"/>
		<amendment number="h18"/>
		<amendment number="h19"/>
	</amendments>
	<summary>
	1/5/1993--Introduced.
TABLE OF CONTENTS: Title I: General Provisions Regarding Title IV of Public Health Service Act Title II: National Institutes of Health in General Title III: General Provisions Respecting National Research Institutes Title IV: National Cancer Institute Title V: National Heart, Lung, and Blood Institute Title VI: National Institute on Diabetes and Digestive and Kidney Diseases Title VII: National Institute on Arthritis and Musculoskeletal and Skin Diseases Title VIII: National Institute on Aging Title IX: National Institute of Allergy and Infectious Diseases Title X: National Institute of Child Health and Human Development Title XI: National Eye Institute Title XII: National Institute of Neurological Disorders and Stroke Title XIII: National Institute of Environmental Health Sciences Title XIV: National Library of Medicine Title XV: Other Agencies of National Institutes of Health Title XVI: Awards and Training Title XVII: National Foundation for Biomedical Research Title XVIII: Research With Respect to Acquired Immune Deficiency Syndrome Title XIX: Studies Title XX: Miscellaneous Provisions Title XXI: Effective Dates National Institutes of Health Revitalization Amendments of 1993 - Title I: General Provisions Regarding title IV of Public Health Service Act - (Sec. 101) Amends the Public Health Service Act to condition research funding on human subject review and scientific and technical peer review. Prohibits withholding funding on ethical grounds unless an ethics advisory board so recommends. (Sec. 111) Regulates human fetal tissue transplantation research. (Sec. 121) Removes provisions regarding: (1) biomedical ethics; (2) waiver of a risk standard; and (3) the construction of title IV (National Research Institutes). Declares ineffective a Federal regulation relating to ethical advisory boards. (Sec. 131) Requires inclusion of women and minorities as subjects in each clinical research project under such title IV. (Sec. 141) Establishes: (1) the Office of Research on Women's Health; (2) the Coordinating Committee on Research on Women's Health; and (3) the Advisory Committee on Research on Women's Health. Mandates: (1) study of the representation of women among senior physicians and scientists of the national research institutes (NRIs) and among those conducting supported research; and (2) activities to increase that representation. Establishes a data system containing information on research on women's health. (Sec. 151) Establishes the Office of Scientific Integrity. Requires grant, contract, or cooperative agreement applicants to have a scientific misconduct report review process. Establishes the Commission on Scientific Integrity. Provides for employee whistle blower protection. Mandates measures against financial conflicts of interest. Title II: National Institutes of Health in General - (Sec. 201) Modifies the duties of the National Institute of Health's (NIH's) Associate Director for Prevention. (Sec. 202) Establishes a program to enhance competitiveness in States receiving little funding from the NRIs. (Sec. 203) Mandates activities, consistent with the global Children's Vaccine Initiative, to develop vaccines. Authorizes appropriations. (Sec. 204) Requires a plan regarding the use of animals in research. Establishes the Interagency Coordinating Committee on the Use of Animals in Research. Repeals similar provisions. (Sec. 205) Authorizes activities to increase the number of women and individuals from disadvantaged backgrounds in biomedical and behavioral research. (Sec. 206) Regulates surveys of human sexual behavior conducted or supported through NIH. (Sec. 207) Establishes a fund for use by the NIH Director to carry out NIH activities. Authorizes appropriations. (Sec. 208) Modifies NRI advisory council terms of office. Requires that at least half of NIH health education materials not exceed functional literacy. Authorizes a day care service for NIH employees. Title III: General Provisions Respecting National Research Institutes - (Sec. 301) Requires that the Secretary of Health and Human Services receive directly all funds appropriated for the Institute. Removes provisions authorizing the National Cancer Institute to directly receive such funds. Modifies requirements regarding the establishment of technical and scientific peer review groups. (Sec. 302) Requires expansion of research on osteoporosis, Paget's disease, and related bone disorders. Establishes a clearinghouse. Authorizes appropriations. (Sec. 303) Establishes a program of trauma research and the Trauma Research Interagency Coordinating Committee. Title IV: National Cancer Institute - (Sec. 401) Requires expanding National Cancer Institute (NCI) activities on breast and ovarian cancer, other cancers of the reproductive system of women, and prostate cancer. Authorizes appropriations. Removes authorizations of appropriations for NCI and the National Heart, Lung, and Blood Institute (NHLBI). Title V: National Heart, Lung, and Blood Institute - (Sec. 501) Requires NHLBI to conduct intramural training and education. Authorizes centers on cardiovascular diseases in children. Establishes the National Center on Sleep Disorders. Authorizes appropriations for NHLBI. Title VI: National Institute on Diabetes and Digestive and Kidney Diseases - (Sec. 601) Establishes a program on nutritional disorders. Provides for research and training centers. Title VII: National Institute on Arthritis and Musculoskeletal and Skin Diseases - (Sec. 701) Establishes a children's arthritis and musculoskeletal disease center. Renames the National Arthritis Advisory Board as the National Arthritis and Musculoskeletal and Skin Diseases Advisory Board and modifies its composition. Title VIII: National Institute on Aging - (Sec. 802) Mandates research into the aging processes of women. Authorizes appropriations for the National Institute on Aging. Title IX: National Institute of Allergy and Infectious Diseases - (Sec. 901) Includes tropical diseases in the purposes of the National Institute of Allergy and Infectious Diseases. Authorizes grants or contracts for centers for research on chronic fatigue syndrome. Establishes an extramural study section. Title X: National Institute of Child Health and Human Development - (Sec. 1001) Mandates grants or contracts for centers on contraception and infertility. Authorizes appropriations. (Sec. 1002) Establishes programs of: (1) agreements with health professionals to conduct research on contraception or infertility in return for educational loan repayment; and (2) obstetrics and gynecology intramural laboratory and clinical research. (Sec. 1021) Mandates child health research center support. (Sec. 1031) Mandates a longitudinal, large-scale study on the well-being of U.S. adolescents. Allocates funding. Title XI: National Eye Institute - (Sec. 1101) Authorizes grants for diabetic eye care clinical research centers. Title XII: National Institute of Neurological Disorders and Stroke - (Sec. 1201) Mandates research on multiple sclerosis. Title XIII: National Institute of Environmental Health Sciences - (Sec. 1301) Establishes the Applied Toxicological Research and Testing Program. Title XIV: National Library of Medicine - (Sec. 1401) Increases the limit on grants to medical libraries and related instrumentalities. Authorizes appropriations for the National Library of Medicine. Mandates grants for new educational technologies research. Establishes the National Information Center on Health Services Research and Health Care Technology. Title XV: Other Agencies of National Institutes of Health - (Sec. 1502) Authorizes grants to alter or construct research facilities. Establishes the Scientific and Technical Review Board on Biomedical and Behavioral Research Facilities. Authorizes appropriations. Reserves funds to construct or improve regional primate research centers. (Sec.1511) Redesignates the National Center for Nursing Research as the National Institute for Nursing Research. (Sec. 1521) Makes the National Center for Human Genome Research an NIH agency. Includes in Center purposes the mapping and sequencing of individual genes. Title XVI: Awards and Training - (Sec.1601) Provides for research recruitment and training for women and individuals from disadvantaged backgrounds. (Sec. 1611) Modifies existing and authorizes or mandates various new programs of scholarships and loan repayments for health professionals' education in exchange for specified service. (Sec. 1641) Authorizes appropriations related to National Research Service Awards. Requires a set-aside for provisions relating to residency programs in general dentistry. Title XVII: National Foundation for Biomedical Research - (Sec. 1701) Mandates the convening, by a specified date, of a meeting to appoint the Board of the National Foundation for Biomedical Research. Adds references to the Stevenson-Wydler Technology Innovation Act of 1980. Authorizes appropriations. Title XVIII: Research with Respect to Acquired Immune Deficiency Syndrome - (Sec. 1801) Modifies the duties of: (1) the AIDS Clinical Research Review Committee; and (2) the acquired immune deficiency syndrome (AIDS) clinical evaluation units at the National Cancer Institute and National Institute of Allergy and Infectious Diseases. Modifies international AIDS efforts support requirements. Authorizes appropriations. Requires that model protocols for clinical AIDS care include treatment and prevention for women. Authorizes appropriations. Requires the AIDS epidemiological data base to include information on the natural history of AIDS infection. Authorizes appropriations. Mandates a comprehensive plan for NIH AIDS research. Authorizes appropriations for fellowship and training programs relating to AIDS. Title XIX: Studies - (Sec. 1901) Mandates studies regarding AIDS on: (1) parallel-track drug-release mechanisms; (2) third-party payment incident to participation as subjects in clinical trials; and (3) coordination of AIDS advisory committees. Requires a plan for the inclusion in NIH human immunodeficiency virus (HIV) vaccine studies of women, infants, and children infected with HIV. Authorizes appropriations. (Sec. 1902) Requires studies on malnutrition and the elderly. Establishes an advisory panel. (Sec. 1903) Mandates reports or studies on NIH: (1) research on chronic fatigue syndrome; (2) assuming responsibility for all Federal research relating to medical countermeasures against biowarfare; (3) support staff retention, recruitment, vacancy, and turnover rates; and (4) procurement. Title XX: Miscellaneous Provisions - (Sec. 2001) Redesignates the Senior Biomedical Research Service as the Silvio O. Conte Senior Biomedical Research Service and increases the limit on the number of its members. (Sec. 2004) Mandates a master plan to replace or refurbish NIH infrastructure. (Sec. 2006) Authorizes appropriations (currently, authorizes the use of funds) to carry out cancer registries provisions. Title XXI: Effective Date - (Sec. 2101) Sets forth the effective date of this Act and its amendments.

	</summary>
</bill>
